Results 331 to 340 of about 327,068 (394)

Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024)

Journal of Evidence-Based Medicine, Volume 18, Issue 2, June 2025.
ABSTRACT Aim Chronic Obstructive Pulmonary Disease (COPD) is a common chronic airway disease that can lead to decreased lung function in patients. It places a heavy economic burden on patients and society. Traditional Chinese medicine (TCM) and Western medicine have played important roles in managing COPD.
Di Wu, Wei Liu, Jianxin Wang, Wei Chen, Mengyao Shi, Lu Zhang, Hui Wang, Huanzhang Ding, Xiao Ma, Yating Gao, Zengtao Sun, Jiangtao Lin, Hongchun Zhang, Suyun Li, Zhuying Li, Zhenhui Lu, Fuqiang Wen, Zegeng Li   +17 more
wiley   +1 more source

Treatable Trait Guided Asthma Management: A Feasibility Study

Respirology, Volume 30, Issue 6, Page 480-492, June 2025.
ABSTRACT Background and Objectives Treatable trait‐based personalised medicine improves outcomes in severe asthma clinics. We assessed the feasibility of a randomised controlled trial (RCT) of protocolised treatable trait‐guided asthma management in patients not under a severe asthma clinic. Methods Ten week single‐group cohort study.
James Fingleton, Rob McLachlan, Jenny Sparks, Richard Beasley, Alvar Agustí, Peter G. Gibson, Ian D. Pavord, Jo Hardy, Mark Weatherall, Allie Eathorne, Vanessa M. McDonald, the Treatable Traits Study Group, James Fingleton, Vanessa M. McDonald, Jo Hardy, Rob McLachlan, Peter G. Gibson, Ian D. Pavord, Alvar Agusti, Mark Weatherall, Richard Beasley, Augustus Anderson, Luisa Diputado, Allie Eathorne, James Fingleton, James Gilchrist, Jo Hardy, Mark Holliday, Kyley Kerse, John Martindale, Rob McLachlan, Nick Shortt, Jenny Sparks, Vanessa McDonald, Peter Gibson, Jasminka Nikolajevic‐Sarunac, Amber Smith, Paola Urroz   +37 more
wiley   +1 more source

Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia. [PDF]

Multidiscip Respir Med
Abu Elhassan U, Al-Mani SY, Alqahtani SMA, Elnamaky M, Alfaifi A, Alshehri MA, Alasiri HA, Kadasah AS, Musleh A, Alshafa FA, Qureshi MSS, Assiri AY, Falqi AI, Asiri BI, Ahmed HMO, Alshehry S, Abdalla AM.   +16 more
europepmc   +1 more source

Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion

Respirology, Volume 30, Issue 6, Page 466-479, June 2025.
ABSTRACT Treatment targets in severe asthma have evolved towards a remission‐focused paradigm guided by precision medicine. This novel concept requires a shift from evaluating the efficacy of therapies based on a single outcome at a single time point to an outcome that captures the complexity of asthma remission involving several domains assessed over ...
Dennis Thomas, Hayley Lewthwaite, Peter G. Gibson, Eleanor Majellano, Vanessa Clark, Michael Fricker, Yuto Hamada, Gary P. Anderson, Vibeke Backer, Philip Bardin, Richard Beasley, Jimmy Chien, Claude S. Farah, John Harrington, Erin Harvey, Mark Hew, Anne E. Holland, Christine Jenkins, Constance H. Katelaris, Gregory Katsoulotos, Kirsty Murray, Matthew Peters, Rejoy Thomas, Katrina Tonga, John W. Upham, Peter Wark, Vanessa M. McDonald   +26 more
wiley   +1 more source

Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study. [PDF]

J Asthma Allergy
Cameli P, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Canonica GW, Caruso C, Centanni S, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Senna G, Vultaggio A, Benci M, Boarino S, Menzella F.   +22 more
europepmc   +1 more source

Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study. [PDF]

Allergy Asthma Clin Immunol
Chapman KR, Cogger K, Arthurs E, LaForty C, Golden S, Millson B, Usuba K, Licskai C.   +7 more
europepmc   +1 more source

Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab. [PDF]

Immunotherapy
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S.   +9 more
europepmc   +1 more source

The Effects of Benralizumab on Lung Volumes and Airway Resistance in Severe Eosinophilic Asthma: A Real-World Study. [PDF]

Cureus
Madeira Gerardo A, da Silva Alves C, Gomes M, Pardal C, Sokolova A, Liberato H, Mendes A, Tonin FS, Duarte-Ramos F, Lopes C.   +9 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source